Dec 2 (Reuters) - Wall Street securities analysts revised their ratings and price
targets on several U.S.-listed companies including HCA Healthcare, Ncino and Progyny, on
Monday.
HIGHLIGHTS
* HCA Healthcare Inc HCA.N : JP Morgan raises target price to $380
from $379
* Ncino Inc NCNO.O : KBW raises target price to $49 from $41
* Progyny Inc PGNY.O : JP Morgan cuts to neutral from overweight
Following is a summary of research actions on U.S. companies reported by Reuters on Monday.
Stock entries are in alphabetical order.
* Ardent Health Partners Inc ARDT.N : JP Morgan raises target price to
$20 from $19
* HCA Healthcare Inc HCA.N : JP Morgan raises target price to $380 from
$379
* Ncino Inc NCNO.O : KBW raises target price to $49 from $41
* Progyny Inc PGNY.O : JP Morgan cuts target price to $17 from $22
* Progyny Inc PGNY.O : JP Morgan cuts to neutral from overweight
* Tenet Healthcare Corp THC.N : JP Morgan raises target price to $175
from $172
(Compiled by Bengaluru Newsroom)
((Diaries@thomsonreuters.com))